Respiratory tract infections in cattle are commonly associated with the bacterial pathogens Mannheimia haemolytica and Pasteurella multocida. These infections can generally be successfully treated in the field with one of several groups of antibiotics, including macrolides. A few recent isolates of these species exhibit resistance to veterinary macrolides with phenotypes that fall into three distinct classes. The first class has type I macrolide, lincosamide, and streptogramin B antibiotic resistance and, consistent with this, the 23S rRNA nucleotide A2058 is monomethylated by the enzyme product of the erm(42) gene. The second class shows no lincosamide resistance and lacks erm(42) and concomitant 23S rRNA methylation. Sequencing of the genome of a representative strain from this class, P. multocida 3361, revealed macrolide efflux and phosphotransferase genes [respectively termed msr(E) and mph(E)] that are arranged in tandem and presumably expressed from the same promoter. The third class exhibits the most marked drug phenotype, with high resistance to all of the macrolides tested, and possesses all three resistance determinants. The combinations of erm(42), msr(E), and mph(E) are chromosomally encoded and intermingled with other exogenous genes, many of which appear to have been transferred from other members of the Pasteurellaceae. The presence of some of the exogenous genes explains recent reports of resistance to additional drug classes. We have expressed recombinant versions of the erm(42), msr(E), and mph(E) genes within an isogenic Escherichia coli background to assess their individually contributions to resistance. Our findings indicate what types of compounds might have driven the selection for these resistance determinants.
The Pasteurellaceae contain several pathogenic species the most common of which are Mannheimia haemolytica (formerly Pasteurella haemolytica), Pasteurella multocida, and Histophilus somni (formerly Haemophilus somnus). These bacteria are the etiological agents of bovine pneumonic pasteurellosis, which is one of the major respiratory tract infections afflicting beef cattle (13, 31) . This form of pneumonia can generally be successfully treated with macrolides or other antibiotics such as aminocylitols, amphenicols, ␤-lactams, fluoroquinolones, sulfonamides, or tetracyclines. However, if undetected, untreated, or inappropriately managed, the disease can develop rapidly causing high rates of morbidity and mortality in feedlots, with an estimated loss over $3 billion per year (34) . Potential complications to the treatment of infections are now evident with the recent emergence of resistant M. haemolytica and P. multocida strains (16, 36) . The mechanisms of resistance in these strains have been characterized for most drugs (16) , with the notable exception of macrolides such as tilmicosin, tulathromycin, and gamithromycin that are used in veterinary medicine (36) .
The lack of specific knowledge about macrolide resistance in the Pasteurellaceae contrasts with the broad general understanding of macrolide mode-of-action and resistance. Macrolides bind to the large subunit of the ribosome to block protein synthesis in bacteria; lincosamide and streptogramin B antibiotics, although structurally different, function in a similar way (23, 39) . Resistance to all or to subsets of the macrolide, lincosamide, and streptogramin B (MLS B ) compounds can be conferred by efflux pumps (20, 25) , drug modification enzymes (3, 38) , and mutations in the ribosomal proteins (r-proteins) L4 or L22 (5, 22, 40) and by mutation (35) or methylation (26, 37) within 23S rRNA.
We report here how field isolates of M. haemolytica and P. multocida display phenotypes with distinctly different patterns of resistance to 14-, 15-, and 16-membered macrolides, indicating that resistance is being conferred by more than one mechanism. We recently showed that one resistance mechanism involves addition of a single methyl group to nucleotide A2058 in 23S rRNA by the product of the monomethyltransferase gene erm(42) (7). The resistance pattern in this first class of isolates is identical to the MLS B type I phenotype, with high resistance to lincosamides and low to moderate resistance to macrolide and streptogramin B antibiotics, which is generally only found in drug-producing actinomycetes (4, 37) . In the present study, we report a second class of isolates that displays macrolide resistance without concomitant lincosamide resistance, and possesses neither an erm gene nor methylation at nucleotide A2058. Further compounding the issue, a third class of the isolates possesses a copy of erm (42) , although the presence of this gene alone was insufficient to explain the high resistance to macrolides.
Full-genome sequencing of a representative strain P. multocida 3361 from the second class of isolates reveals that it contains genes encoding a macrolide efflux pump and a macrolide phosphotransferase enzyme, and these genes are respectively named msr(E) and mph(E). These genes are arranged in tandem and expressed from the same promoter. The third class of highly resistant isolates is shown to contain all three erm (42) , msr(E), and mph(E) determinants. Mapping of the locations and arrangements of erm (42) , msr(E), and mph(E) in different strains showed that resistance is chromosomally encoded and interspersed with genes previously noted in members of the Pasteurellaceae and other Gram-negative bacteria. We assessed the individually contributions of erm (42) , msr(E), and mph(E) to resistance by expressing recombinant versions of the genes within an isogenic Escherichia coli background. The data provide clues as to the specific types of antimicrobials that might have driven the selection for these macrolide resistance determinants.
MATERIALS AND METHODS
Bacterial strains and culture conditions. M. haemolytica strains 6055, 6056, 11935, and 12548 and P. multocida strains 3358, 3361, 4407, 6052, 6053, 6054, and 12602 (Table 1) are field isolates obtained from nasal swabs of cattle in the United States; the sensitive P. multocida strain 4407 originated in France. All were procured from the Intervet Culture Collection (Intervet Innovation GmbH, Germany). E. coli strain DH1 (27) , a standard recA laboratory strain, was used for genetic manipulations. E. coli strain AS19rlmA
I (17, 28) was used for MIC studies with antibiotics. The latter strain has a membrane defect that increases its susceptibility to 14-, 15-, and 16-membered macrolides and lincosamides by facilitating their intracellular accumulation; in addition, the methyltransferase gene responsible for modification of 23S rRNA nucleotide m 1 G745 (rlmA I ) was inactivated so that this modification could not interfere with macrolide binding (23, 41) . The equivalent nucleotide in M. haemolytica and P. multocida rRNAs is unmodified (7) . Antibiotics used for plasmid/strain selection and MIC testing were the lincosamide clindamycin (Upjohn-Pharmacia) and the macrolides erythromycin, tilmicosin, and tylosin (Sigma), gamithromycin extracted and purified from Zactran (Merial), and tulathromycin extracted and purified from Draxxin (Pfizer). Purified gamithromycin and tulathromycin were obtained as colorless powders, and their structures were verified by liquid chromatographymass spectrometry and nuclear magnetic resonance analyses.
rRNA isolation and MALDI-MS analysis. M. haemolytica and P. multocida strains were grown with aeration in 200 ml of brain heart infusion broth (Oxoid) to mid-log phase at an optical density of 0.6 (A 600 ). E. coli strains were grown in a similar manner in rich LB medium (27) . Cells were harvested by centrifugation and lysed, and ribosomes were prepared by differential centrifugation (7); rRNAs were purified by phenol-chloroform extraction (32) . The methylation status of nucleotide A2058 in the 23S rRNAs was determined by matrix-assisted laser desorption ionization-mass spectrometry (MALDI-MS) (2, 7) .
DNA preparation for PCR and genome sequencing. M. haemolytica and P. multocida strains were grown to stationary phase in 10 ml of brain heart infusion broth prior to DNA preparation. Cells were recovered and washed before being lysed by addition of a 1/8 volume of 5% sodium dodecyl sulfate, 0.125 M EDTA, and 0.5 M Tris-Cl (pH 8.0), followed by protease and RNase A treatment. The lysate was phenol-chloroform extracted three times, and DNA was recovered from the aqueous phase by ethanol precipitation. A solution of DNA from P. multocida strain 3361 was nebulized to yield fragments in the size range 100 to 600 bp. The genome sequence was determined by Solexa (Illumina Genome Analyzer II) sequencing (29) with Ͼ500 times sequence coverage. The pairedend sequences were assembled using the de novo short read assembler Edena (14) .
Screening and reconstructing the 3361 genome. BLAST searches were carried out by standard techniques (1) and software available at web databases using known and characterized macrolide resistance genes as queries. These included genes encoding the methyltransferases of the erm family, various mef and msr efflux genes, and macrolide modification genes, including mph phosphotransferases, ereA, ereB, and ere-like esterases, and glycosylases such as mgt (9, 33, 38) . Alignments were made using MUSCLE multiple sequence alignment algorithms (8) . After identification of the P. multocida 3361 contig containing the msr(E) and mph(E) genes, its sequence was extended by inverse and unpredictably primed PCR methods (21, 30) , followed by Sanger dideoxy sequencing of PCR fragments. The PCR primers for this process and for the screening of strains for the erm (42) , msr(E), and mph(E) genes are listed in Table 2 .
Recombinant macrolide resistance genes in E. coli. The erm (42) gene was amplified by PCR from 3358 genomic DNA using the enzyme Phusion highfidelity DNA polymerase (Finnzymes); likewise, msr(E) and mph(E) genes were amplified from 3361 DNA, both individually and as a tandem pair. The PCR fragment from P. multocida 3358 was subjected to a second round of nested PCR to introduce restriction sites for cloning into the expression vector pLJ102 (15) under the control of the lac promoter (7). The msr(E) and mph(E) genes were cloned individually and as a pair in a similar manner, as was the A2058 dimethyltransferase erm(E) that was used as a positive control to confer high MLS B resistance (18) . Recombinant plasmids were used to transform E. coli DH1 and were checked by restriction analysis before being moved into the AS19rlmA I strain. In summary, five recombinant plasmids were constructed to express erm (42) , erm(E), msr(E), and mph(E) individually from the lacP promoter and msr(E) and mph(E) as a tandem pair from a single lacP promoter.
Determination of MICs. The MICs of macrolide and lincosamide antibiotics were determined for the M. haemolytica and P. multocida isolates and E. coli AS19rlmA I containing the plasmid pLJ102 derivatives. Strains were grown on the media described above; IPTG (isopropyl-␤-D-thiogalactopyranoside) at 1 mM was added to express the pLJ102-encoded genes. MIC measurements were carried out in microtiter plates with the addition of antibiotics in 2-fold dilution steps between 0.5 and 1,024 g/ml. Cells were incubated at 37°C and MICs were scored after 20 h as the lowest concentration at which no growth was observed.
Nucleotide sequence accession number. The sequence data for the 10.5-kb region of the P. multocida 3361 genome shown in Fig. 1 has been deposited at the National Center for Biotechnology Information under GenBank accession number JF769133. 
RESULTS AND DISCUSSION
Phenotypes of M. haemolytica and P. multocida isolates. The recent identification of M. haemolytica and P. multocida field isolates with high MICs for macrolides prompted us to investigate the resistance mechanisms in these strains. We note that at present the majority of M. haemolytica and P. multocida strains isolated from cattle with respiratory tract infections have remained susceptible to macrolide antibiotics. These are represented here by strains M. haemolytica 11935 and P. multocida 4407 that are sensitive to MLS B antibiotics and lack all of the resistance determinants for which we tested. The antibiotic MICs that inhibited growth were tested for a range of macrolide drugs currently used in veterinary medicine and also for the lincosamide clindamycin. For all of these drugs, the MIC values for the sensitive strains fell between 0.5 and 4 g/ml (Table 1 ). In contrast, the MIC values for the resistant isolates were higher by 8-to Ͼ128-fold and, on the basis of their various patterns of lincosamide and macrolide resistance, the phenotypes of the resistant isolates could be grouped into three distinct classes (Table 1) .
Macrolide resistance by monomethylation of 23S rRNA. The first class of resistant isolates has an MLS B type I phenotype and is represented here by strains 6052, 6053, and 6054. These strains displayed high lincosamide resistance (clindamycin MIC ϭ 1,024 g/ml) and low to moderate resistance to macrolides; notably, despite slightly elevated gamithromycin and tulathromycin MICs, they remained susceptible to these macrolides. MALDI-MS analyses of the 23S rRNAs from these strains showed that nucleotide A2058 was monomethylated, a finding consistent with the MLS B type I phenotype. The enzyme responsible for A2058 monomethylation is encoded by the recently discovered erm (42) gene (7), and the presence of erm (42) was confirmed by PCR analysis of genomic DNA (Table 2).
Macrolide resistance by efflux and phosphotransferase. The second class of isolates-represented here by strains 3361, FIG. 1. Site of integration of resistance genes in the P. multocida 3361 genome. The msr(E) (black arrow) and mph(E) (hatched arrow) are shown as a tandem couple within a stretch of exogenous sequence inserted in the P. multocida chromosome (19) between the PM1937 (GenBank code NP_246876) and PM1938 (NP_246877) genes (plain arrows). Neighboring exogenous genes (dotted arrows) have sequence identity to the hypothetical proteins HSM_1733 in Histophilus somni 2336 (YP_001785053) and MHA_1160 (EDN74093) in M. haemolytica PHL213 (a), the tetracycline repressor protein TetR found in Actinobacillus pleuropneumoniae (YP_001569045) and H. somnus 2336 (YP_001785054) (b), an aminoglycoside adenyltransferase in E. coli (ACJ47203) and Salmonella enterica (ADF35688) (c), another aminoglycoside adenyltransferase in S. enterica subsp. enterica serovar Rissen (ABL95942) (d), the OXA-2 ␤-lactamase in S. enterica serovar Typhimurium (ACS54283), Pseudomonas aeruginosa (ABA26529), and Klebsiella pneumoniae (CAJ13501) (e), and duplicated sequences for a putative transposase TnpA in several S. enterica subspecies (NP_872582) (f). The amino acid sequence identity between 3361 and these bacteria is 100% for a, b, and f and 99% for c, d, and e. The PCR primers used for sequence verification ( (19) . BLAST screening of the contigs using known resistance determinants as queries identified two relevant open reading frames (ORFs) that correspond to a macrolide efflux pump and a macrolide phosphotransferase. The ORFs were found on a contig of 4,075 bp (contig 44), the structure of which was confirmed by PCR and Sanger sequencing. PCR-based approaches facilitated assembly with several other smaller contigs to extend the overall contiguous sequence to 10.5 kb (Fig. 1) . The efflux and phosphotransferase genes are named msr(E) and mph(E), respectively, according to the nomenclature system for macrolide resistance determinants (http://faculty .washington.edu/marilynr).
The resistance phenotypes of 3361, 12548, and 12602 in the second class of isolates (Table 1) is largely explained by the presence of the macrolide efflux gene msr(E) and the adjacently situated macrolide phosphotransferase gene mph(E). Efflux mechanisms of the msr(E) type are known to confer resistance to the 14-membered macrolide erythromycin and its 15-membered derivative, azithromycin (25, 38) , which fits with the resistance observed for the similar compound tulathromycin. This efflux mechanism and the accompanying phosphotransferase are, however, generally regarded as being ineffective against 16-membered macrolides and lincosamides (and this conviction is confirmed here by the E. coli data described below); therefore, the elevated MICs observed for tilmicosin and clindamycin in the second class of Pasteurellaceae strains was surprising. A rigorous search of the strain 3361 genome data revealed no other genes or alterations in ribosomal components that could account for the higher MICs of tilmicosin and clindamycin. Presumably some other change, which has remained undetected by our screening approaches, has occurred in these strains. One possibility is increased expression of an intrinsic gene, such as the upregulation of an efflux pump in Acinetobacter baumannii that was recently reported to confer resistance to several drugs, including clindamycin (6) .
Genome locations of msr(E) and mph(E).
The exogenous sequence containing the resistance genes is located immediately adjacent to the 3Ј end of the indigenous gene PM1938 in the chromosome of P. multocida strain 3361. No promoter sequence is evident between msr(E) and mph(E), and thus the genes appear to be expressed from the same promoter upstream as msr(E) (Fig. 1) . The sequences and tandem arrangement of msr(E) and mph(E) are identical to genes that have been seen on plasmids isolated from Enterobacteriaceae (11) (12) and A. baumannii (24, 43) , where there were respectively called mel and mph. Several other resistance genes, including aminoglycoside adenyltransferases are distributed around msr(E) and mph(E) within the P. multocida 3361 exogenous sequence (Fig. 1) .
The extra sequence in the genome of P. multocida strain 3361 has undoubtedly arisen from a collection of sources and includes genes that have previously been identified in Actinobacillus pleuropneumoniae and Histophilus somni (Fig. 1) , which are related members of the Pasteurellaceae family. Other genes are evident that have been noted in the Enterobacteriaceae E. coli, Salmonella spp., and Klebsiella pneumoniae, and, further afield, in Pseudomonas aeruginosa. The lack of variation within these gene sequences (legend to Fig. 1) suggests that their acquisition by the Pasteurellaceae, and consequently that of msr(E), mph(E), and erm(42) (7), has been a relatively recent event. However, the locations of these genes vary within the exogenous sequences of the different Pasteurellaceae strains (Fig. 1) (7) . It remains unclear whether these differences in location result from multiple sequence transfer events or from gene rearrangement.
Combinations of macrolide resistance genes in P. multocida and M. haemolytica strains. The resistance mechanisms in the third class of strains became evident upon PCR screening with primers designed from the erm (42) , msr(E), and mph(E) sequences (Table 2 ). This third class was shown to contain all three of the macrolide resistant determinants, where msr(E) and mph(E) have retained the same tandem-pair arrangement and are located on a different contig than erm (42) . Similar PCR analyses of the two other strain classes yielded results consistent with their phenotypes: in the first class, strains 6052, 6053, and 6054 gave a PCR product with primers p1 and p2 specific for erm (42) , but no product with any combination of the p35 to p40 primers for detecting msr(E) and mph(E); conversely, strains 3361, 12548, and 12602 in the second class of strains gave PCR products with the msr(E) and mph(E) primers but no product with the erm(42) primers (Table 1) .
The PCR products encompassed the entire erm (42) , msr(E), and mph(E) genes and were sequenced by the Sanger dideoxy method. The sequences were identical to the Solexa Illumina data, and the coding region within each of the resistance genes was absolutely conserved in all of the isolates. The tandem organization of msr(E) and mph(E) was maintained in the second and third classes of strains; none of the strains contained msr(E) in the absence of mph(E) or vice versa.
The individual contributions of erm(42), mph(E), and msr(E) to resistance. The presence of three different macrolide resistance determinants in the Pasteurellaceae strains prompted the question regarding what antimicrobial compounds might have driven their selection. This was addressed by expressing recombinant versions of erm (42) , mph(E), and msr(E) from an identical promoter in an isogenic E. coli background and then evaluated their contributions to resistance (Table 3 ).
In the absence of any resistance determinant, the E. coli strain used here is susceptible to erythromycin, gamithromycin, tilmicosin, tulathromycin, and tylosin (MICs of 1 to 2 g/ml) and shows a basal MIC of 16 g/ml for the lincosamide clindamycin. As a positive control, we constructed a recombinant version of this strain expressing the dimethyltransferase erm(E), which confers a type II MLS B phenotype with high resistance to all of these compounds ( Table 3) . Monitoring of the rRNA methylation status by MALDI-MS showed that modification at nucleotide A2058 was close to stoichiometric (data not shown) and verified that the Erm (42) (18, 38, 42) . After monomethylation by erm (42) , the MIC of erythromycin increased the most, whereas the gamithromycin and tylosin MICs were least affected. As expected, dimethylation by ermE conferred high resistance to all of the macrolides. Lincosamide resistance is conferred to the same high level by both monoand dimethylation of the 23S rRNA at nucleotide A2058 (38, 42) , and the consistently high MIC values for clindamycin (Table 3) confirmed this prediction and showed that erm (42) and erm(E) were being efficiently expressed. Taken together, these findings suggest that lincosamides, and to a lesser extent erythromycin, could have exerted selective pressure for acquiring and maintaining erm (42) . Although no lincosamides are indicated against M. haemolytica and P. multocida infections, a lincomycin-spectinomycin combination has been used in the treatment of bovine respiratory disease (10) . Otherwise, lincosamide use in cattle is generally limited to the topical application of pirlimycin to treat mastitis caused by Gram-positive bacteria (10) .
The msr(E) and mph(E) determinants conferred narrower resistance phenotypes than the erm genes. The Msr(E) efflux pump was most effective against tulathromycin (MIC of 64 g/ml) and to a lesser extent against erythromycin and gamithromycin. In E. coli, the msr(E) efflux system was generally not effective against 16-membered macrolides and lincosamide antibiotics, although a single-step increase in the MIC for tilmicosin was observed ( Table 3 ), indicating that the pump did excrete a modest amount of the drug. This latter observation does not explain the higher tilmicosin resistance observed in the second class of Pasteurellaceae isolates ( Table 1) .
The phenotype conferred by the mph(E)-encoded phosphotransferase was the least extensive of the three resistance determinants. Functioning alone, mph(E) conferred a modest increase in the MIC to erythromycin, but it was ineffective against the other drugs tested ( Table 3 ). The protective value of mph(E) was only apparent when functioning synergistically together with msr(E) to confer appreciably higher resistance to erythromycin. Identical copies of the two conserved genes are encoded on plasmids in other Gram-negative species (11, 24, 43) , and since their tandem organization is only advantageous in resisting erythromycin and closely related macrolides, it would seem that erythromycin was initially the agent that led to the selection and maintenance of this gene pair.
Divining the path that led to the resistance genotype found in the third class of isolates is less straightforward. It is not clear whether lincosamides or erythromycin could have exerted sufficient selective pressure to collect all three erm (42) , mph(E), and msr(E) resistance genes, and thus the mechanisms behind their combined selection and maintenance in the same strain are still to be resolved. (42) , erm(E), msr(E)/mph(E) as a tandem pair, or msr(E) or mph(E) individually. All resistance genes were under the control of the lac promoter. The gene for the dimethyltransferase Erm(E) was cloned from Saccharopolyspora erythraea (18) . MICs were measured for the lincosamide clindamycin and for erythromycin (a 14-membered ring macrolide), tulathromycin and gamithromycin (15-membered), and tylosin and tilmicosin (16-membered) , which are the most commonly used macrolides in veterinary medicine. The methylation status of the 23S rRNA at nucleotide A2058 was established by MALDI-MS (7).
